GO:1905369 endopeptidase complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905369 (endopeptidase complex) is a cellular component defined as a protein complex capable of endopeptidase activity, with the proteasome as its best-characterized example.
• The 26S proteasome is a multicatalytic endopeptidase complex that degrades ubiquitin-tagged proteins and is essential for protein quality control.
• Endopeptidase complexes participate in diverse processes including cell-cycle control, apoptosis, antigen presentation, and signal transduction.
• Dysfunction of endopeptidase complexes is linked to neurodegeneration, cancer, and muscle wasting.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of endopeptidase complex components.
• Assembly of the proteasome endopeptidase complex is a highly regulated, stepwise process involving dedicated chaperones.
Description
GO:1905369, endopeptidase complex, is a Gene Ontology cellular component term that describes any protein complex capable of endopeptidase activity. Endopeptidases cleave peptide bonds within polypeptide chains, and when such activity is embedded in a multimeric assembly, the complex often gains substrate specificity, regulation, and processivity that a free enzyme lacks. The most extensively studied endopeptidase complex is the proteasome, a multicatalytic machine that degrades ubiquitinated proteins. The proteasome was originally described as a multicatalytic endopeptidase complex because it contains multiple active sites with distinct cleavage preferences. Because endopeptidase complexes control the half-life of regulatory proteins, they are central to virtually every cellular pathway, from cell-cycle progression to immune surveillance. Researchers study GO:1905369 to understand how protein degradation is compartmentalized, how complexes assemble, and how their dysfunction contributes to disease.
endopeptidase complex At A Glance
| GO ID | GO:1905369 |
|---|---|
| GO term | endopeptidase complex |
| Ontology | cellular_component |
| Synonym | none |
| Definition | A protein complex which is capable of endopeptidase activity. |
| Major function | ATP-dependent and ATP-independent degradation of intracellular proteins, including ubiquitinated substrates. |
| Example complex | 26S proteasome, composed of a 20S catalytic core and 19S regulatory particles. |
| Catalytic subunits | Beta-type subunits with caspase-like, trypsin-like, and chymotrypsin-like activities. |
| Related pathway | Ubiquitin-proteasome system (UPS). |
What Is GO:1905369?
According to the Gene Ontology, GO:1905369 (endopeptidase complex) is a protein complex which is capable of endopeptidase activity. This means the complex as a whole can catalyze the hydrolysis of internal peptide bonds in a polypeptide substrate. The term is a cellular component annotation, so it describes where the activity resides rather than the activity itself. A single gene product may contribute to the complex, but the endopeptidase activity is a property of the assembled multimer.
Why Is endopeptidase complex Important in Cell Biology?
Endopeptidase complexes are essential for maintaining proteostasis and for executing regulated proteolysis. By selectively destroying short-lived regulatory proteins, they control cell-cycle transitions, apoptosis, and stress responses. Their dysfunction is implicated in neurodegeneration, cancer, and metabolic disorders, making them important drug targets.
• Controls degradation of ubiquitinated proteins, a central mechanism of intracellular proteolysis.
• Regulates cell-cycle progression by degrading cyclins and CDK inhibitors.
• Participates in antigen processing for MHC class I presentation.
• Maintains protein quality control by removing misfolded proteins.
• Contributes to muscle protein turnover and atrophy.
• Is a target of proteasome inhibitors used in cancer therapy.
• Assembly defects can cause proteasome-associated autoinflammatory syndromes.
• Provides a model for studying multimeric enzyme assembly and allostery.
• Links ubiquitin signaling to downstream degradation.
• Plays roles in DNA repair, transcription, and signal transduction.
What Happens During endopeptidase complex?
Substrate recognition and ubiquitination
In simple terms: Proteins are tagged with a chain of ubiquitin molecules before they are destroyed.
The ubiquitin system attaches polyubiquitin chains to target proteins through E1, E2, and E3 enzymes. This tagging marks substrates for recognition by the endopeptidase complex. The specificity of degradation is largely determined at this step, linking ubiquitin signaling to the complex.
Binding and unfolding at the regulatory particle
In simple terms: The proteasome's regulatory cap grabs the tagged protein and unfolds it.
The 19S regulatory particle of the 26S proteasome recognizes polyubiquitinated substrates, removes the ubiquitin chain, and uses ATP to unfold and translocate the substrate into the 20S core. This ATP-dependent step ensures that only properly tagged proteins are degraded.
Proteolysis in the catalytic core
In simple terms: Inside the barrel-shaped core, the protein is cut into small peptides.
The 20S core particle is a barrel-shaped structure with catalytic beta subunits that cleave peptide bonds via a threonine protease mechanism. The complex exhibits multiple endopeptidase activities, including trypsin-like, chymotrypsin-like, and caspase-like cleavage. Peptide products are released and further degraded by cytosolic peptidases.
Assembly of the endopeptidase complex
In simple terms: The proteasome is built from many subunits with the help of dedicated assembly factors.
Proteasome assembly is a highly ordered process. The 20S core forms from alpha and beta subunits with the help of chaperones such as PAC1-PAC2 and POMP. The 19S regulatory particle assembles separately and then docks onto the 20S core to form the 26S holoenzyme. Defects in assembly can lead to proteasome storage granules or disease.
Key Genes Involved in GO:1905369 endopeptidase complex
The following genes encode core components, regulators, and assembly factors of endopeptidase complexes, with emphasis on the proteasome.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PSMA1 | 20S core alpha subunit | Structural scaffold; knockout affects core assembly. |
| PSMB1 | 20S core beta subunit | Catalytic subunit precursor; mutations alter activity. |
| PSMB5 | Chymotrypsin-like catalytic subunit | Target of bortezomib; point mutations confer resistance. |
| PSMB6 | Caspase-like catalytic subunit | Defines cleavage specificity. |
| PSMB7 | Trypsin-like catalytic subunit | Contributes to substrate diversity. |
| PSMC1 | 19S ATPase subunit | Required for substrate unfolding and translocation. |
| PSMD1 | 19S regulatory particle subunit | Scaffold for regulatory particle assembly. |
| POMP | Proteasome maturation protein | Chaperone for 20S assembly; mutations cause disease. |
| PAC1 | 20S assembly chaperone | Assists alpha-ring formation. |
| PAC2 | 20S assembly chaperone | Assists beta-ring formation. |
| UBB | Ubiquitin precursor | Provides ubiquitin for tagging substrates. |
| UBC | Ubiquitin conjugating enzyme | Mediates ubiquitin transfer. |
| UBE3A | E3 ubiquitin ligase | Imprinted gene; mutations cause Angelman syndrome. |
| PSMD14 | Deubiquitinating enzyme in 19S | Removes ubiquitin before degradation. |
| PSMA7 | 20S alpha subunit | Interacts with viral proteins; host factor. |
| PSMB8 | Immunoproteasome subunit | Induced by interferon; antigen processing. |
| PSMB9 | Immunoproteasome subunit | Replaces constitutive subunit in immune cells. |
| PSMB10 | Immunoproteasome subunit | Alters cleavage specificity for MHC presentation. |
How Is endopeptidase complex Regulated?
Endopeptidase complex activity is regulated at multiple levels. Transcription of proteasome subunit genes is controlled by Nrf1 and other stress-responsive factors. Assembly is regulated by chaperones such as POMP and PAC1-PAC2. Post-translational modifications, including phosphorylation and ubiquitination of regulatory particles, modulate substrate recognition. Additionally, the ubiquitin system itself is tightly regulated by E3 ligases and deubiquitinating enzymes, determining which proteins are delivered to the complex.
endopeptidase complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PSMB5 | Bortezomib resistance in myeloma | Point mutation knock-in in myeloma cell lines. |
| POMP | Proteasome-associated autoinflammatory syndrome | Knockout or point mutation in iPSCs. |
| UBE3A | Angelman syndrome | Knockout in neurons. |
| PSMB8 | Immunoproteasome deficiency | Knockout in immune cells. |
| PSMC1 | Neurodegeneration | Conditional knockout in mouse brain. |
Neurodegeneration
Impaired endopeptidase complex function leads to accumulation of ubiquitinated proteins, a hallmark of neurodegenerative diseases such as Alzheimer's and Parkinson's. Mutations in proteasome subunits or assembly factors can cause neurodegeneration.
Cancer
Cancer cells are often dependent on the proteasome for survival and proliferation. Proteasome inhibitors like bortezomib target the endopeptidase complex and are used to treat multiple myeloma. Mutations in PSMB5 can confer resistance.
Muscle wasting
The ubiquitin-proteasome pathway is upregulated in muscle atrophy, making endopeptidase complexes potential therapeutic targets.
Autoinflammatory syndromes
Mutations in proteasome assembly chaperones or subunits cause proteasome-associated autoinflammatory syndromes (PRAAS).
From endopeptidase complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of complete loss of a catalytic subunit? | CRISPR knockout cell line. |
| How does a specific active-site mutation affect substrate specificity? | Point mutation knock-in. |
| How does a disease-associated mutation affect assembly? | Knock-in of patient mutation. |
| Where is the complex localized in live cells? | Tagged knock-in with fluorescent protein. |
| What happens when a subunit is overexpressed? | Overexpression cell line. |
| Which genes are essential for complex function? | Genome-wide CRISPR library screening. |
How to Study the endopeptidase complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Mass spectrometry | Subunit composition and interactors | Purification of endogenous complex. |
| Fluorogenic peptide assay | Catalytic activity | Drug screening and mutant analysis. |
| Live-cell imaging | Localization and dynamics | Tagged knock-in cell lines. |
| CRISPR knockout screen | Gene essentiality | Identifying regulators of complex function. |
| RNA-seq | Transcriptional changes | Response to proteasome inhibition. |
| Western blot | Protein levels and ubiquitin conjugates | Assessing degradation capacity. |
| Immunoprecipitation | Protein-protein interactions | Mapping assembly intermediates. |
| Ribo-seq | Translation efficiency | Stress response to complex dysfunction. |
Proteomics and interactomics
Affinity purification coupled with mass spectrometry can identify subunits and interactors of endopeptidase complexes. Quantitative proteomics measures changes in complex abundance and composition.
Activity assays
Fluorogenic peptide substrates are used to measure trypsin-like, chymotrypsin-like, and caspase-like activities of the complex. These assays are standard for assessing proteasome function.
Imaging
Fluorescent tagging of subunits enables live-cell imaging of complex assembly and localization. Super-resolution microscopy reveals subcellular distribution.
CRISPR screening
Genome-wide CRISPR knockout screens can identify genes required for endopeptidase complex function or resistance to inhibitors.
How CRISPR Can Be Used to Study GO:1905369 endopeptidase complex
Knockout
CRISPR knockout of core proteasome subunits such as PSMA1 or PSMB5 abolishes endopeptidase complex activity and is often lethal, making conditional or inducible systems necessary. Knockout of assembly chaperones like POMP leads to accumulation of assembly intermediates.
Point Mutation
Point mutations in catalytic threonine residues of beta subunits (e.g., PSMB5 T1A) eliminate specific endopeptidase activities without disrupting complex assembly, allowing dissection of individual active sites.
Knock-in
Knock-in of disease-associated mutations, such as those in PSMB8 or POMP, recapitulates autoinflammatory phenotypes and provides models for drug testing.
Overexpression
Overexpression of immunoproteasome subunits PSMB8, PSMB9, or PSMB10 alters antigen processing and can enhance MHC class I presentation.
How EDITGENE Supports endopeptidase complex Research
Researchers studying endopeptidase complex-related genes often need to determine whether a candidate gene is causally involved in complex assembly, substrate degradation, or disease. EDITGENE provides tailored CRISPR services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for endopeptidase complex research.
Frequently Asked Questions About endopeptidase complex
What is GO:1905369 endopeptidase complex?
GO:1905369 is a Gene Ontology cellular component term for a protein complex capable of endopeptidase activity, such as the proteasome.
What genes are involved in endopeptidase complex?
Genes include PSMA1, PSMB1-7, PSMC1, PSMD1, POMP, PAC1, PAC2, and ubiquitin pathway genes like UBB and UBE3A.
What is the function of the proteasome endopeptidase complex?
It degrades ubiquitinated proteins, controlling cell-cycle, apoptosis, and immune responses.
How is the endopeptidase complex assembled?
The 20S core assembles with chaperones, then docks with the 19S regulatory particle to form the 26S proteasome.
What diseases are linked to endopeptidase complex dysfunction?
Neurodegeneration, cancer, muscle wasting, and autoinflammatory syndromes.
How can CRISPR be used to study endopeptidase complexes?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of subunits.
What are the catalytic activities of the proteasome?
Trypsin-like, chymotrypsin-like, and caspase-like endopeptidase activities.
Is the proteasome an endopeptidase complex?
Yes, the 26S proteasome is a multicatalytic endopeptidase complex.
What is the role of ubiquitin in endopeptidase complex function?
Ubiquitin tags substrates for recognition and degradation by the complex.
How is endopeptidase complex activity regulated?
By transcription, assembly chaperones, post-translational modifications, and ubiquitin ligases.
Conclusion
GO:1905369 endopeptidase complex represents a fundamental cellular component that executes regulated protein degradation. Its best-studied example, the proteasome, is essential for proteostasis, cell-cycle control, and immunity. Dysregulation contributes to major human diseases, making it a prime target for therapeutic intervention. CRISPR-based models are powerful tools to dissect the function of individual subunits and assembly factors.
References
- 1. Hershko A et al.. 1998. The ubiquitin system.. Annu Rev Biochem 67:425-79 PMID: 9759494
- 2. Burgunder JM. 2003. Neurodegeneration.. IUBMB Life 55(6):291 PMID: 12938729
- 3. Bochtler M et al.. 1999. The proteasome.. Annu Rev Biophys Biomol Struct 28:295-317 PMID: 10410804
- 4. Rivett AJ et al.. 1994. Multicatalytic endopeptidase complex: proteasome.. Methods Enzymol 244:331-50 PMID: 7845218
- 5. Liu XM et al.. 2019. Assembly en route.. Nat Struct Mol Biol 26(2):89-91 PMID: 30692645
- 6. Rivett AJ. 1990. Eukaryotic protein degradation.. Curr Opin Cell Biol 2(6):1143-9 PMID: 1966008
- 7. Attaix D et al.. 2001. Regulation of proteolysis.. Curr Opin Clin Nutr Metab Care 4(1):45-9 PMID: 11122559
- 8. Roos-Mattjus P et al.. 2004. The ubiquitin-proteasome pathway.. Ann Med 36(4):285-95 PMID: 15224655
